Display Settings:

Format

Send to:

Choose Destination

    J Assoc Physicians India. 1991 Aug;39(8):613-5.

    Clinical profile of giardiasis and comparison of its therapeutic response to metronidazole and tinidazole.

    Nigam P, Kapoor KK, Kumar A, Sarkari NB, Gupta AK.

    Department of Medicine, BRD Medical College and Nehru Chikitsalaya, Gorakhpur, UP.

    Seventy five cases (50 males, 25 females; mean age 20.2 +/- 5.8 years), whose stools were positive for cysts and/or trophozoites of Giardia lamblia, were studied for their clinical profile and therapeutic response to metronidazole and tinidazole. Maximum frequency of cases (41.2%) was noted upto 20 years of age, and it declined with advancing age. A majority of them (41.3%) presented with non-specific symptoms while 38.6% were asymptomatic parasite carriers. Features of malabsorption were observed in 12% of cases and 8% presented with acute illness, having explosive, watery, foul smelling diarrhoea along with crampy upper abdominal discomfort. Most of them (62.5%) had blood group A. Tinidazole (97.5%) was more efficacious (P less than 0.01) than metronidazole (54%) in a single dose of 50 mg/Kg, with good tolerance. Tinidazole can be recommended for the treatment of giardiasis in individual cases as well as in families and close communities.

    PMID: 1814877 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Patient drug information

    • Tinidazole (Tindamax®)

      Tinidazole is used to treat trichomoniasis (a sexually transmitted disease that can affect men and women), giardiasis (an infection of the intestine that can cause diarrhea, gas, and stomach cramps), and amebiasis (an in...